Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Effect of heterozygous beta thalassemia on HbA1c levels in individuals without diabetes mellitus: A cross sectional study.

Tsilingiris D, Makrilakis K, Voskaridou E, Pagkrati S, Dalamaga M, Liatis S.

Clin Chim Acta. 2019 Mar 13. pii: S0009-8981(19)31716-4. doi: 10.1016/j.cca.2019.03.1611. [Epub ahead of print]

PMID:
30878538
2.

Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale European cohort. The Feel4Diabetes-study.

Mavrogianni C, Lambrinou CP, Androutsos O, Lindström J, Kivelä J, Cardon G, Huys N, Tsochev K, Iotova V, Chakarova N, Rurik I, Moreno LA, Liatis S, Makrilakis K, Manios Y; Feel4Diabetes-study group.

Diabetes Res Clin Pract. 2019 Feb 20;150:99-110. doi: 10.1016/j.diabres.2019.02.017. [Epub ahead of print]

PMID:
30796939
3.

National Survey of Morbidity and Risk Factors (EMENO): Protocol for a Health Examination Survey Representative of the Adult Greek Population.

Touloumi G, Karakatsani A, Karakosta A, Sofianopoulou E, Koustenis P, Gavana M, Alamanos Y, Kantzanou M, Konstantakopoulos G, Chryssochoou X, Benos A, Vantarakis A, Hadjichristodoulou C, Chlouverakis G, Trypsianis G, Voulgari PV, Makrilakis K, Liatis S, Stergiou G; EMENO Study Group.

JMIR Res Protoc. 2019 Feb 4;8(2):e10997. doi: 10.2196/10997.

4.

A school- and community-based intervention to promote healthy lifestyle and prevent type 2 diabetes in vulnerable families across Europe: design and implementation of the Feel4Diabetes-study.

Manios Y, Androutsos O, Lambrinou CP, Cardon G, Lindstrom J, Annemans L, Mateo-Gallego R, de Sabata MS, Iotova V, Kivela J, Martinez R, Moreno LA, Rurik I, Schwarz P, Tankova T, Liatis S, Makrilakis K.

Public Health Nutr. 2018 Dec;21(17):3281-3290. doi: 10.1017/S1368980018002136. Epub 2018 Sep 12.

PMID:
30207513
5.

Comparison of health-related quality of Life (HRQOL) among patients with pre-diabetes, diabetes and normal glucose tolerance, using the 15D-HRQOL questionnaire in Greece: the DEPLAN study.

Makrilakis K, Liatis S, Tsiakou A, Stathi C, Papachristoforou E, Perrea D, Katsilambros N, Kontodimopoulos N, Niakas D.

BMC Endocr Disord. 2018 May 29;18(1):32. doi: 10.1186/s12902-018-0261-3.

6.

Gaps in Guidelines for the Management of Diabetes in Low- and Middle-Income Versus High-Income Countries-A Systematic Review.

Owolabi MO, Yaria JO, Daivadanam M, Makanjuola AI, Parker G, Oldenburg B, Vedanthan R, Norris S, Oguntoye AR, Osundina MA, Herasme O, Lakoh S, Ogunjimi LO, Abraham SE, Olowoyo P, Jenkins C, Feng W, Bayona H, Mohan S, Joshi R, Webster R, Kengne AP, Trofor A, Lotrean LM, Praveen D, Zafra-Tanaka JH, Lazo-Porras M, Bobrow K, Riddell MA, Makrilakis K, Manios Y, Ovbiagele B; COUNCIL Initiative.

Diabetes Care. 2018 May;41(5):1097-1105. doi: 10.2337/dc17-1795. Review.

PMID:
29678866
7.

Cardiovascular Screening for the Asymptomatic Patient with Diabetes: More Cons Than Pros.

Makrilakis K, Liatis S.

J Diabetes Res. 2017;2017:8927473. doi: 10.1155/2017/8927473. Epub 2017 Dec 14. Review.

8.

Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors.

Bistola V, Lambadiari V, Dimitriadis G, Ioannidis I, Makrilakis K, Tentolouris N, Tsapas A, Parissis J.

Heart Fail Rev. 2018 May;23(3):377-388. doi: 10.1007/s10741-018-9674-3. Review.

PMID:
29383638
9.

Antidiabetic Drugs as Antihypertensives: New Data on the Horizon.

Mamakou V, Eleftheriadou I, Katsiki N, Makrilakis K, Tsioufis K, Tentolouris N.

Curr Vasc Pharmacol. 2017;16(1):70-78. doi: 10.2174/1570161115666171010122332. Review.

PMID:
29032756
10.

Hypoglycaemia causes both daytime and nighttime QTc interval prolongation in patients with type 2 diabetes receiving insulin treatment.

Makrilakis K, Stathi C, Vlahodimitris I, Kalopita S, Thomakos P, Konstantopoulos P, Perrea D, Katsilambros N, Liatis S.

Diabetes Metab. 2018 Mar;44(2):175-177. doi: 10.1016/j.diabet.2017.08.005. Epub 2017 Oct 10. No abstract available.

PMID:
29029946
11.

The prevalence and treatment patterns of diabetes in the Greek population based on real-world data from the nation-wide prescription database.

Liatis S, Dafoulas GE, Kani C, Politi A, Litsa P, Sfikakis PP, Makrilakis K.

Diabetes Res Clin Pract. 2016 Aug;118:162-7. doi: 10.1016/j.diabres.2016.06.018. Epub 2016 Jun 17.

PMID:
27372056
12.

The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus.

Protogerou AD, Fransen J, Zampeli E, Argyris AA, Aissopou E, Arida A, Konstantonis GD, Tentolouris N, Makrilakis K, Psichogiou M, Daikos G, Kitas GD, Sfikakis PP.

PLoS One. 2015 Jul 31;10(7):e0132307. doi: 10.1371/journal.pone.0132307. eCollection 2015.

13.

Information seeking behavior of patients with diabetes mellitus: a cross-sectional study in an outpatient clinic of a university-affiliated hospital in Athens, Greece.

Kalantzi S, Kostagiolas P, Kechagias G, Niakas D, Makrilakis K.

BMC Res Notes. 2015 Feb 20;8:48. doi: 10.1186/s13104-015-1005-3.

14.

Chemerin and cardiovascular risk in rheumatoid arthritis after interleukin 6 receptor blockade.

Makrilakis K, Fragiadaki K, Sfikakis PP, Kitas GD.

J Rheumatol. 2015 Feb;42(2):349. doi: 10.3899/jrheum.141115. No abstract available.

PMID:
25641970
15.

The effect of consumption of low-glycemic-index and low-glycemic-load desserts on anthropometric parameters and inflammatory markers in patients with type 2 diabetes mellitus.

Argiana V, Kanellos PΤ, Makrilakis K, Eleftheriadou I, Tsitsinakis G, Kokkinos A, Perrea D, Tentolouris N.

Eur J Nutr. 2015 Oct;54(7):1173-80. doi: 10.1007/s00394-014-0795-8. Epub 2014 Dec 5.

PMID:
25475658
16.

Relationship between autonomic nervous system function and continuous interstitial glucose measurement in patients with type 2 diabetes.

Kalopita S, Liatis S, Thomakos P, Vlahodimitris I, Stathi C, Katsilambros N, Tentolouris N, Makrilakis K.

J Diabetes Res. 2014;2014:835392. doi: 10.1155/2014/835392. Epub 2014 Aug 3.

17.

Interrelated reduction of chemerin and plasminogen activator inhibitor-1 serum levels in rheumatoid arthritis after interleukin-6 receptor blockade.

Makrilakis K, Fragiadaki K, Smith J, Sfikakis PP, Kitas GD.

Clin Rheumatol. 2015 Mar;34(3):419-27. doi: 10.1007/s10067-014-2704-1. Epub 2014 Jun 10.

PMID:
24912961
18.

Baseline osteocalcin levels and incident diabetes in a 3-year prospective study of high-risk individuals.

Liatis S, Sfikakis PP, Tsiakou A, Stathi C, Terpos E, Katsilambros N, Makrilakis K.

Diabetes Metab. 2014 Jun;40(3):198-203. doi: 10.1016/j.diabet.2014.01.001. Epub 2014 Feb 12.

PMID:
24529960
19.

Glucagon-like peptide-1 receptor agonists vs. insulin in inadequately controlled patients with type 2 diabetes. Is this meta-analysis miscalculated?

Liatis S, Makrilakis K.

Diabetes Obes Metab. 2014 Mar;16(3):284. doi: 10.1111/dom.12213. No abstract available.

PMID:
24495116
20.

Effect of atorvastatin on baroreflex sensitivity in subjects with type 2 diabetes and dyslipidaemia.

Grigoropoulou P, Eleftheriadou I, Zoupas C, Makrilakis K, Papassotiriou I, Margeli A, Perrea D, Katsilambros N, Tentolouris N.

Diab Vasc Dis Res. 2014 Jan;11(1):26-33. doi: 10.1177/1479164113508293. Epub 2013 Oct 23.

PMID:
24154932
21.

Standard and emerging treatment options for diabetic neuropathy.

Tentolouris N, Alexiadou K, Makrilakis K, Liatis S, Jude E, Boulton AJ.

Curr Pharm Des. 2014;20(22):3689-704. Review.

PMID:
24040869
22.

Cigarette Smoking Is Associated with Prolongation of the QTc Interval Duration in Patients with Type 2 Diabetes Mellitus.

Thomakos P, Liatis S, Kalopita S, Vlahodimitris I, Stathi C, Katsilambros N, Tentolouris N, Makrilakis K.

Int J Endocrinol. 2013;2013:329189. doi: 10.1155/2013/329189. Epub 2013 Apr 24.

23.

The performance of serum inflammatory markers for the diagnosis and follow-up of patients with osteomyelitis.

Michail M, Jude E, Liaskos C, Karamagiolis S, Makrilakis K, Dimitroulis D, Michail O, Tentolouris N.

Int J Low Extrem Wounds. 2013 Jun;12(2):94-9. doi: 10.1177/1534734613486152. Epub 2013 May 9.

PMID:
23667102
24.

Antihypertensive treatment in diabetic patients. Review of current data.

Argyrakopoulou G, Tsioufis C, Sdraka E, Tsiachris D, Makrilakis K, Stefanadis C.

Maturitas. 2013 Jun;75(2):142-7. doi: 10.1016/j.maturitas.2013.03.012. Epub 2013 Apr 17. Review.

PMID:
23602543
25.

Arterial stiffness is inversely related to plasma adiponectin levels in young normotensive patients with type 1 diabetes.

Tsiakou A, Liatis S, Alexiadou K, Diakoumopoulou E, Makrilakis K, Tentolouris N, Kyriaki D, Katsilambros N.

Diabetes Care. 2013 Mar;36(3):734-6. doi: 10.2337/dc12-0387. Epub 2012 Sep 21.

26.

The effect of a non-intensive community-based lifestyle intervention on the prevalence of metabolic syndrome. The DEPLAN study in Greece.

Makrilakis K, Grammatikou S, Liatis S, Kontogianni M, Perrea D, Dimosthenopoulos C, Poulia KA, Katsilambros N.

Hormones (Athens). 2012 Jul-Sep;11(3):316-24.

27.

Subclinical femoral atheromatosis in rheumatoid arthritis: comparable prevalence to diabetes mellitus in a case-control study.

Protogerou A, Zampeli E, Tentolouris N, Makrilakis K, Kitas G, Sfikakis PP.

Ann Rheum Dis. 2012 Sep;71(9):1534-6. doi: 10.1136/annrheumdis-2011-201278. Epub 2012 Jul 4.

PMID:
22764043
28.

Periodontitis and diabetes: a two-way relationship.

Preshaw PM, Alba AL, Herrera D, Jepsen S, Konstantinidis A, Makrilakis K, Taylor R.

Diabetologia. 2012 Jan;55(1):21-31. doi: 10.1007/s00125-011-2342-y. Epub 2011 Nov 6. Review.

29.

Changes in dietary habits and their association with metabolic markers after a non-intensive, community-based lifestyle intervention to prevent type 2 diabetes, in Greece. The DEPLAN study.

Kontogianni MD, Liatis S, Grammatikou S, Perrea D, Katsilambros N, Makrilakis K.

Diabetes Res Clin Pract. 2012 Feb;95(2):207-14. doi: 10.1016/j.diabres.2011.09.010. Epub 2011 Sep 28.

PMID:
21955962
30.

Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.

Strawbridge RJ, Dupuis J, Prokopenko I, Barker A, Ahlqvist E, Rybin D, Petrie JR, Travers ME, Bouatia-Naji N, Dimas AS, Nica A, Wheeler E, Chen H, Voight BF, Taneera J, Kanoni S, Peden JF, Turrini F, Gustafsson S, Zabena C, Almgren P, Barker DJ, Barnes D, Dennison EM, Eriksson JG, Eriksson P, Eury E, Folkersen L, Fox CS, Frayling TM, Goel A, Gu HF, Horikoshi M, Isomaa B, Jackson AU, Jameson KA, Kajantie E, Kerr-Conte J, Kuulasmaa T, Kuusisto J, Loos RJ, Luan J, Makrilakis K, Manning AK, Martínez-Larrad MT, Narisu N, Nastase Mannila M, Ohrvik J, Osmond C, Pascoe L, Payne F, Sayer AA, Sennblad B, Silveira A, Stancáková A, Stirrups K, Swift AJ, Syvänen AC, Tuomi T, van 't Hooft FM, Walker M, Weedon MN, Xie W, Zethelius B; DIAGRAM Consortium; GIANT Consortium; MuTHER Consortium; CARDIoGRAM Consortium; C4D Consortium, Ongen H, Mälarstig A, Hopewell JC, Saleheen D, Chambers J, Parish S, Danesh J, Kooner J, Ostenson CG, Lind L, Cooper CC, Serrano-Ríos M, Ferrannini E, Forsen TJ, Clarke R, Franzosi MG, Seedorf U, Watkins H, Froguel P, Johnson P, Deloukas P, Collins FS, Laakso M, Dermitzakis ET, Boehnke M, McCarthy MI, Wareham NJ, Groop L, Pattou F, Gloyn AL, Dedoussis GV, Lyssenko V, Meigs JB, Barroso I, Watanabe RM, Ingelsson E, Langenberg C, Hamsten A, Florez JC.

Diabetes. 2011 Oct;60(10):2624-34. doi: 10.2337/db11-0415. Epub 2011 Aug 26.

31.

Cardiac autonomic function correlates with arterial stiffness in the early stage of type 1 diabetes.

Liatis S, Alexiadou K, Tsiakou A, Makrilakis K, Katsilambros N, Tentolouris N.

Exp Diabetes Res. 2011;2011:957901. doi: 10.1155/2011/957901. Epub 2011 Jul 24.

32.

Effect of non-surgical periodontal therapy on C-reactive protein, oxidative stress, and matrix metalloproteinase (MMP)-9 and MMP-2 levels in patients with type 2 diabetes: a randomized controlled study.

Koromantzos PA, Makrilakis K, Dereka X, Offenbacher S, Katsilambros N, Vrotsos IA, Madianos PN.

J Periodontol. 2012 Jan;83(1):3-10. doi: 10.1902/jop.2011.110148. Epub 2011 May 31.

PMID:
21627458
33.

Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece.

Makrilakis K, Liatis S, Grammatikou S, Perrea D, Stathi C, Tsiligros P, Katsilambros N.

Diabetes Metab. 2011 Apr;37(2):144-51. doi: 10.1016/j.diabet.2010.09.006. Epub 2010 Dec 7.

PMID:
21144787
34.

A randomized, controlled trial on the effect of non-surgical periodontal therapy in patients with type 2 diabetes. Part I: effect on periodontal status and glycaemic control.

Koromantzos PA, Makrilakis K, Dereka X, Katsilambros N, Vrotsos IA, Madianos PN.

J Clin Periodontol. 2011 Feb;38(2):142-7. doi: 10.1111/j.1600-051X.2010.01652.x. Epub 2010 Nov 29.

PMID:
21114680
35.

Implementation and effectiveness of the first community lifestyle intervention programme to prevent Type 2 diabetes in Greece. The DE-PLAN study.

Makrilakis K, Liatis S, Grammatikou S, Perrea D, Katsilambros N.

Diabet Med. 2010 Apr;27(4):459-65. doi: 10.1111/j.1464-5491.2010.02918.x.

PMID:
20536519
36.

Vinegar reduces postprandial hyperglycaemia in patients with type II diabetes when added to a high, but not to a low, glycaemic index meal.

Liatis S, Grammatikou S, Poulia KA, Perrea D, Makrilakis K, Diakoumopoulou E, Katsilambros N.

Eur J Clin Nutr. 2010 Jul;64(7):727-32. doi: 10.1038/ejcn.2010.89. Epub 2010 May 26.

PMID:
20502468
37.

Acute hyperhomocysteinaemia blunts endothelial dependent and endothelial independent vasodilatation in diabetic patients.

Chousos I, Perrea D, Kyriaki D, Liatis S, Katsilambros N, Makrilakis K.

Diab Vasc Dis Res. 2010 Jul;7(3):186-94. doi: 10.1177/1479164110369687. Epub 2010 May 14.

PMID:
20472601
38.

Quality indicators for the prevention of type 2 diabetes in Europe--IMAGE.

Pajunen P, Landgraf R, Muylle F, Neumann A, Lindström J, Schwarz PE, Peltonen M, Acosta T, Adler M, AlKerwi A, Barengo N, Barengo R, Boavida JM, Charlesworth K, Christov V, Claussen B, Cos X, Cosson E, Deceukelier S, Dimitrijevic-Sreckovic V, Djordjevic P, Evans P, Felton AM, Fischer M, Gabriel-Sanchez R, Gilis-Januszewska A, Goldfracht M, Gomez JL, Greaves CJ, Hall M, Handke U, Hauner H, Herbst J, Hermanns N, Herrebrugh L, Huber C, Hühmer U, Huttunen J, Jotic A, Kamenov Z, Karadeniz S, Katsilambros N, Khalangot M, Kissimova-Skarbek K, Köhler D, Kopp V, Kronsbein P, Kulzer B, Kyne-Grzebalski D, Lalic K, Lalic N, Landgraf R, Lee-Barkey YH, Liatis S, Lindström J, Makrilakis K, McIntosh C, McKee M, Mesquita AC, Misina D, Muylle F, Neumann A, Paiva AC, Pajunen P, Paulweber B, Peltonen M, Perrenoud L, Pfeiffer A, Pölönen A, Puhl S, Raposo F, Reinehr T, Rissanen A, Robinson C, Roden M, Rothe U, Saaristo T, Scholl J, Schwarz PE, Sheppard KE, Spiers S, Stemper T, Stratmann B, Szendroedi J, Szybinski Z, Tankova T, Telle-Hjellset V, Terry G, Tolks D, Toti F, Tuomilehto J, Undeutsch A, Valadas C, Valensi P, Velickiene D, Vermunt P, Weiss R, Wens J, Yilmaz T.

Horm Metab Res. 2010 Apr;42 Suppl 1:S56-63. doi: 10.1055/s-0029-1240976. Epub 2010 Apr 13.

39.

Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe.

Lindström J, Neumann A, Sheppard KE, Gilis-Januszewska A, Greaves CJ, Handke U, Pajunen P, Puhl S, Pölönen A, Rissanen A, Roden M, Stemper T, Telle-Hjellset V, Tuomilehto J, Velickiene D, Schwarz PE, Acosta T, Adler M, AlKerwi A, Barengo N, Barengo R, Boavida JM, Charlesworth K, Christov V, Claussen B, Cos X, Cosson E, Deceukelier S, Dimitrijevic-Sreckovic V, Djordjevic P, Evans P, Felton AM, Fischer M, Gabriel-Sanchez R, Gilis-Januszewska A, Goldfracht M, Gomez JL, Greaves CJ, Hall M, Handke U, Hauner H, Herbst J, Hermanns N, Herrebrugh L, Huber C, Hühmer U, Huttunen J, Jotic A, Kamenov Z, Karadeniz S, Katsilambros N, Khalangot M, Kissimova-Skarbek K, Köhler D, Kopp V, Kronsbein P, Kulzer B, Kyne-Grzebalski D, Lalic K, Lalic N, Landgraf R, Lee-Barkey YH, Liatis S, Lindström J, Makrilakis K, McIntosh C, McKee M, Mesquita AC, Misina D, Muylle F, Neumann A, Paiva AC, Pajunen P, Paulweber B, Peltonen M, Perrenoud L, Pfeiffer A, Pölönen A, Puhl S, Raposo F, Reinehr T, Rissanen A, Robinson C, Roden M, Rothe U, Saaristo T, Scholl J, Schwarz PE, Sheppard KE, Spiers S, Stemper T, Stratmann B, Szendroedi J, Szybinski Z, Tankova T, Telle-Hjellset V, Terry G, Tolks D, Toti F, Tuomilehto J, Undeutsch A, Valadas C, Valensi P, Velickiene D, Vermunt P, Weiss R, Wens J, Yilmaz T.

Horm Metab Res. 2010 Apr;42 Suppl 1:S37-55. doi: 10.1055/s-0029-1240975. Epub 2010 Apr 13.

PMID:
20391307
40.

A European evidence-based guideline for the prevention of type 2 diabetes.

Paulweber B, Valensi P, Lindström J, Lalic NM, Greaves CJ, McKee M, Kissimova-Skarbek K, Liatis S, Cosson E, Szendroedi J, Sheppard KE, Charlesworth K, Felton AM, Hall M, Rissanen A, Tuomilehto J, Schwarz PE, Roden M, Paulweber M, Stadlmayr A, Kedenko L, Katsilambros N, Makrilakis K, Kamenov Z, Evans P, Gilis-Januszewska A, Lalic K, Jotic A, Djordevic P, Dimitrijevic-Sreckovic V, Hühmer U, Kulzer B, Puhl S, Lee-Barkey YH, AlKerwi A, Abraham C, Hardeman W, Acosta T, Adler M, AlKerwi A, Barengo N, Barengo R, Boavida JM, Charlesworth K, Christov V, Claussen B, Cos X, Cosson E, Deceukelier S, Dimitrijevic-Sreckovic V, Djordjevic P, Evans P, Felton AM, Fischer M, Gabriel-Sanchez R, Gilis-Januszewska A, Goldfracht M, Gomez JL, Greaves CJ, Hall M, Handke U, Hauner H, Herbst J, Hermanns N, Herrebrugh L, Huber C, Hühmer U, Huttunen J, Jotic A, Kamenov Z, Karadeniz S, Katsilambros N, Khalangot M, Kissimova-Skarbek K, Köhler D, Kopp V, Kronsbein P, Kulzer B, Kyne-Grzebalski D, Lalic K, Lalic N, Landgraf R, Lee-Barkey YH, Liatis S, Lindström J, Makrilakis K, McIntosh C, McKee M, Mesquita AC, Misina D, Muylle F, Neumann A, Paiva AC, Pajunen P, Paulweber B, Peltonen M, Perrenoud L, Pfeiffer A, Pölönen A, Puhl S, Raposo F, Reinehr T, Rissanen A, Robinson C, Roden M, Rothe U, Saaristo T, Scholl J, Schwarz PE, Sheppard KE, Spiers S, Stemper T, Stratmann B, Szendroedi J, Szybinski Z, Tankova T, Telle-Hjellset V, Terry G, Tolks D, Toti F, Tuomilehto J, Undeutsch A, Valadas C, Valensi P, Velickiene D, Vermunt P, Weiss R, Wens J, Yilmaz T.

Horm Metab Res. 2010 Apr;42 Suppl 1:S3-36. doi: 10.1055/s-0029-1240928. Epub 2010 Apr 13.

41.

Moisture status of the skin of the feet assessed by the visual test neuropad correlates with foot ulceration in diabetes.

Tentolouris N, Voulgari C, Liatis S, Kokkinos A, Eleftheriadou I, Makrilakis K, Marinou K, Katsilambros N.

Diabetes Care. 2010 May;33(5):1112-4. doi: 10.2337/dc09-2027. Epub 2010 Feb 11.

42.

Metabolic syndrome and Mediterranean dietary pattern in a sample of young, male, Greek navy recruits.

Doupis J, Dimosthenopoulos C, Diamanti K, Perrea D, Katsilambros N, Makrilakis K.

Nutr Metab Cardiovasc Dis. 2009 Jul;19(6):e7-8. doi: 10.1016/j.numecd.2009.03.008. Epub 2009 May 27. No abstract available.

PMID:
19477625
43.

Clinical evaluation of affirm VP III in the detection and identification of bacterial vaginosis.

Pappas S, Makrilakis K, Anyfantis I, Mitroussia-Ziouva A, Hadjisoteriou M, Petrikkos G.

J Chemother. 2008 Dec;20(6):764-5. No abstract available.

PMID:
19129080
44.

Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation.

Alexandraki KI, Piperi C, Ziakas PD, Apostolopoulos NV, Makrilakis K, Syriou V, Diamanti-Kandarakis E, Kaltsas G, Kalofoutis A.

J Clin Immunol. 2008 Jul;28(4):314-21. doi: 10.1007/s10875-007-9164-1. Epub 2008 Jan 26.

PMID:
18224429
45.

Oxcarbazepine as monotherapy of acute mania in insufficiently controlled type-1 diabetes mellitus: a case-report.

Oulis P, Karapoulios E, Kouzoupis AV, Masdrakis VG, Kontoangelos KA, Makrilakis K, Karakatsanis NA, Papageorgiou C, Katsilambros N, Soldatos CR.

Ann Gen Psychiatry. 2007 Oct 8;6:25.

46.

Correlation of family history of obesity and diabetes mellitus with the BMI of Greek medical students.

Makrilakis K, Lavranos G, Nikolaou A, Koliaki C, Doufexis D, Katsilambros N.

Nutr Metab Cardiovasc Dis. 2008 Mar;18(3):e7-8. Epub 2007 Sep 27. No abstract available.

PMID:
17900883
47.

Affirm VP III in the detection and identification of Candida species in vaginitis.

Petrikkos G, Makrilakis K, Pappas S.

Int J Gynaecol Obstet. 2007 Jan;96(1):39-40. Epub 2006 Dec 21. No abstract available.

PMID:
17187795
48.

Prediction and prevention of type 2 diabetes.

Makrilakis K, Katsilambros N.

Hormones (Athens). 2003 Jan-Mar;2(1):22-34.

49.

Critical review of the international guidelines: what is agreed upon--what is not?

Katsilambros N, Liatis S, Makrilakis K.

Nestle Nutr Workshop Ser Clin Perform Programme. 2006;11:207-18; discussion 218. Review.

PMID:
16820742
50.

Increased plasma ghrelin levels in chronic renal failure are not associated with hemodynamic parameters.

Tentolouris N, Makrilakis K, Doulgerakis D, Moyssakis I, Kokkinos A, Kyriaki D, Georgoulias C, Stathakis C, Katsilambros N.

Horm Metab Res. 2005 Oct;37(10):646-52.

PMID:
16278789

Supplemental Content

Loading ...
Support Center